This narrative review examines what is known regarding sources of risk for depression in youth with ADHD in the areas of epidemiology, genetics, neuroanatomy, neuropsychological functioning, social functioning, maltreatment and the effects
of psychopharmacologic treatments.
Not exact matches
Comprehensive, up - to - date coverage
of ADHD in all ages, including co-occurring issues, new
psychopharmacologic medications and cognitive and behavioral therapy techniques.
However, though it was clear that many patients with depression relapsed after termination
of acute tricyclic antidepressant treatment, there was no data regarding how long
psychopharmacologic treatment should continue.